{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:38:20Z","timestamp":1789601900390,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.prp.2025.156301","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:27:06Z","timestamp":1763746026000},"page":"156301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting the NR4A3-RNF139-ATF6 pathway as a therapeutic and diagnostic strategy in bladder cancer"],"prefix":"10.1016","volume":"278","author":[{"given":"Haiyang","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prp.2025.156301_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"10061","key":"10.1016\/j.prp.2025.156301_bib2","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.prp.2025.156301_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2025.156301_bib4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU Guidelines on muscle-invasive and metastatic bladder cancer","volume":"71","author":"Alfred Witjes","year":"2017","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.prp.2025.156301_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00345-006-0061-7","article-title":"Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure","volume":"24","author":"Stein","year":"2006","journal-title":"World J. Urol."},{"issue":"2","key":"10.1016\/j.prp.2025.156301_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0022-5347(17)42387-1","article-title":"Natural history and treatment of low and high risk superficial bladder tumors","volume":"139","author":"R\u00fcbben","year":"1988","journal-title":"J. Urol."},{"issue":"7679","key":"10.1016\/j.prp.2025.156301_bib7","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1038\/551S51a","article-title":"Bladder cancer: 4 big questions","volume":"551","author":"Berdik","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.prp.2025.156301_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/uog.21958","article-title":"Imaging in gynecological disease (18): clinical and ultrasound characteristics of urinary bladder malignancies","volume":"56","author":"Knez","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.prp.2025.156301_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12880-024-01199-3","article-title":"Application of contrast-enhanced ultrasound in diagnosis and grading of bladder urothelial carcinoma","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Med. Imaging"},{"issue":"2","key":"10.1016\/j.prp.2025.156301_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.juro.2009.10.024","article-title":"Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer","volume":"183","author":"Eissa","year":"2010","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.prp.2025.156301_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.56434\/j.arch.esp.urol.20237601.7","article-title":"Fibronectin-1: a predictive immunotherapy response biomarker for muscle\u2011invasive bladder cancer","volume":"76","author":"Zhang","year":"2023","journal-title":"Arch. Esp. Urol."},{"issue":"4","key":"10.1016\/j.prp.2025.156301_bib12","doi-asserted-by":"crossref","first-page":"298","DOI":"10.56434\/j.arch.esp.urol.20237604.34","article-title":"The relationship between VEGF and AGT gene single nucleotide polymorphisms and susceptibility to renal and bladder cancers","volume":"76","author":"Su","year":"2023","journal-title":"Arch. Esp. Urol."},{"issue":"24","key":"10.1016\/j.prp.2025.156301_bib13","doi-asserted-by":"crossref","first-page":"6310","DOI":"10.1182\/blood-2010-12-325555","article-title":"Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder\/acute myelogenous leukemia","volume":"118","author":"Bluteau","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.prp.2025.156301_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108328","article-title":"Nr4a1 and Nr4a3 reporter mice are differentially sensitive to T cell receptor signal strength and duration","volume":"33","author":"Jennings","year":"2020","journal-title":"Cell Rep."},{"issue":"20","key":"10.1016\/j.prp.2025.156301_bib15","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/s41388-022-02303-z","article-title":"Matriptase-2\/NR4A3 axis switches TGF-\u03b2 action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis","volume":"41","author":"Lin","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.156301_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.abb.2018.09.013","article-title":"Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3","volume":"660","author":"Zhang","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"issue":"12","key":"10.1016\/j.prp.2025.156301_bib17","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/s41388-018-0566-8","article-title":"Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis","volume":"38","author":"Fedorova","year":"2019","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.prp.2025.156301_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2021.151745","article-title":"Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665\/NR4A3 axis","volume":"123","author":"Fan","year":"2021","journal-title":"Acta Histochem."},{"key":"10.1016\/j.prp.2025.156301_bib19","doi-asserted-by":"crossref","first-page":"1377989","DOI":"10.1155\/2021\/1377989","article-title":"MiR-20a-5p negatively regulates NR4A3 to promote metastasis in bladder cancer","volume":"2021","author":"Yang","year":"2021","journal-title":"J. Oncol."},{"issue":"24","key":"10.1016\/j.prp.2025.156301_bib20","doi-asserted-by":"crossref","first-page":"6850","DOI":"10.1111\/febs.15776","article-title":"A guide to the composition and functions of the extracellular matrix","volume":"288","author":"Karamanos","year":"2021","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.prp.2025.156301_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/jmp5040029","article-title":"Oncomatrix: molecular composition and biomechanical properties of the extracellular matrix in human tumors","volume":"5","author":"Klabukov","year":"2024","journal-title":"J. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2025.156301_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.prp.2025.156301_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2025.156301_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12943-024-01945-9","article-title":"Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer","volume":"23","author":"Xie","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2025.156301_bib25","doi-asserted-by":"crossref","first-page":"1793005","DOI":"10.1155\/2022\/1793005","article-title":"Prediction of prognosis and recurrence of bladder cancer by ECM-related genes","volume":"2022","author":"Zhao","year":"2022","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.prp.2025.156301_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1186\/s12885-024-12489-y","article-title":"Basement membrane-related MMP14 predicts poor prognosis and response to immunotherapy in bladder cancer","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.prp.2025.156301_bib27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.trecan.2025.05.003","article-title":"The extracellular matrix in cancer: from understanding to targeting","volume":"11","author":"Chitty","year":"2025","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.prp.2025.156301_bib28","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/sj.cdd.4401723","article-title":"Anoikis","volume":"12","author":"Gilmore","year":"2005","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.prp.2025.156301_bib29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1083\/jcb.124.4.619","article-title":"Disruption of epithelial cell-matrix interactions induces apoptosis","volume":"124","author":"Frisch","year":"1994","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.prp.2025.156301_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10585-022-10172-9","article-title":"Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis","volume":"39","author":"Khan","year":"2022","journal-title":"Clin. Exp. Metastas.."},{"issue":"2","key":"10.1016\/j.prp.2025.156301_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","article-title":"Endoplasmic reticulum stress signals in the tumour and its microenvironment","volume":"21","author":"Chen","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2025.156301_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-pathol-012513-104649","article-title":"The role of endoplasmic reticulum stress in human pathology","volume":"10","author":"Oakes","year":"2015","journal-title":"Annu Rev. Pathol."},{"issue":"20","key":"10.1016\/j.prp.2025.156301_bib33","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/onc.2009.77","article-title":"Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals","volume":"28","author":"Giannoni","year":"2009","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.prp.2025.156301_bib34","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1074\/jbc.RA118.002829","article-title":"The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress","volume":"294","author":"Luhr","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"6430","key":"10.1016\/j.prp.2025.156301_bib35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.aat7186","article-title":"Epithelial endoplasmic reticulum stress orchestrates a protective IgA response","volume":"363","author":"Grootjans","year":"2019","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.prp.2025.156301_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091462","article-title":"Elevation of NR4A3 expression and its possible role in modulating insulin expression in the pancreatic beta cell","volume":"9","author":"Gao","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.prp.2025.156301_bib37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 World Health Organization classification of tumors of the urinary system and male genital organs\u2014part B: prostate and urinary tract tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.prp.2025.156301_bib38","first-page":"93","article-title":"The Eighth Edition AJCC Cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"31","key":"10.1016\/j.prp.2025.156301_bib39","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1038\/onc.2009.139","article-title":"Anchorage-independent cell growth signature identifies tumors with metastatic potential","volume":"28","author":"Mori","year":"2009","journal-title":"Oncogene"},{"issue":"22","key":"10.1016\/j.prp.2025.156301_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228444","article-title":"Pygenic Acid A (PA) sensitizes metastatic breast cancer cells to anoikis and inhibits metastasis in vivo","volume":"21","author":"Lim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2025.156301_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41419-021-04494-x","article-title":"ATF4\/CEMIP\/PKC\u03b1 promotes anoikis resistance by enhancing protective autophagy in prostate cancer cells","volume":"13","author":"Yu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.prp.2025.156301_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/ATVBAHA.115.306891","article-title":"Antithrombotic effects of Nur77 and Nor1 are mediated through upregulating thrombomodulin expression in endothelial cells","volume":"36","author":"Yang","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.prp.2025.156301_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111373","article-title":"Function of Nr4a orphan nuclear receptors in proliferation, apoptosis and fuel utilization across tissues","volume":"8","author":"Herring","year":"2019","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.prp.2025.156301_bib44","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1158\/1078-0432.CCR-11-2953","article-title":"Molecular pathways: the role of NR4A orphan nuclear receptors in cancer","volume":"18","author":"Mohan","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.prp.2025.156301_bib45","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1111\/jcmm.14942","article-title":"Long non-coding RNA LINC00467 drives hepatocellular carcinoma progression via inhibiting NR4A3","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"9","key":"10.1016\/j.prp.2025.156301_bib46","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1158\/0008-5472.CAN-16-2320","article-title":"NR4A3 suppresses lymphomagenesis through induction of proapoptotic genes","volume":"77","author":"Deutsch","year":"2017","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2025.156301_bib47","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1109\/TCBB.2020.2973148","article-title":"FUNMarker: fusion network-based method to identify prognostic and heterogeneous breast cancer biomarkers","volume":"18","author":"Li","year":"2021","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"issue":"8","key":"10.1016\/j.prp.2025.156301_bib48","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s12031-021-01860-4","article-title":"An E3 ubiquitin ligase RNF139 serves as a tumor-suppressor in glioma","volume":"71","author":"Chen","year":"2021","journal-title":"J. Mol. Neurosci."},{"issue":"18","key":"10.1016\/j.prp.2025.156301_bib49","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/onc.2012.244","article-title":"TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation","volume":"32","author":"Lin","year":"2013","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2025.156301_bib50","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12885-017-3438-7","article-title":"E3 ubiquitin ligase, RNF139, inhibits the progression of tongue cancer","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prp.2025.156301_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109249","article-title":"Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response","volume":"118","author":"Lin","year":"2019","journal-title":"Biomed. Pharm."},{"issue":"11","key":"10.1016\/j.prp.2025.156301_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2024.130706","article-title":"COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma","volume":"1868","author":"Wu","year":"2024","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"1","key":"10.1016\/j.prp.2025.156301_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13062-024-00518-6","article-title":"Disulfidptosis signature predicts immune microenvironment and prognosis of gastric cancer","volume":"19","author":"Liu","year":"2024","journal-title":"Biol. Direct"},{"key":"10.1016\/j.prp.2025.156301_bib54","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-immunol-032414-112116","article-title":"Endoplasmic reticulum stress in immunity","volume":"33","author":"Bettigole","year":"2015","journal-title":"Annu Rev. Immunol."},{"issue":"7","key":"10.1016\/j.prp.2025.156301_bib55","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1172\/JCI78031","article-title":"ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis","volume":"125","author":"Dey","year":"2015","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.prp.2025.156301_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1534-5807(02)00203-4","article-title":"ER stress regulation of ATF6 localization by dissociation of BiP\/GRP78 binding and unmasking of Golgi localization signals","volume":"3","author":"Shen","year":"2002","journal-title":"Dev. Cell"},{"issue":"4","key":"10.1016\/j.prp.2025.156301_bib57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO Guideline: 2024 Amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2025.156301_bib58","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1741-7015-11-104","article-title":"Advances in bladder cancer imaging","volume":"11","author":"Hafeez","year":"2013","journal-title":"BMC Med."},{"issue":"7","key":"10.1016\/j.prp.2025.156301_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/life14070857","article-title":"The current role of contrast-enhanced ultrasound (CEUS) in the diagnosis and staging of bladder cancer: a review of the available literature","volume":"14","author":"Santarelli","year":"2024","journal-title":"Life"},{"issue":"12","key":"10.1016\/j.prp.2025.156301_bib60","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/jsxmed\/qdad140","article-title":"Clitoris color Doppler ultrasound: a 2023 update","volume":"20","author":"Maseroli","year":"2023","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.prp.2025.156301_bib61","first-page":"1047948","article-title":"Contrast-enhanced ultrasound in the bladder: critical features to differentiate occupied lesions","volume":"2021","author":"Liu","year":"2021","journal-title":"Comput. Math. Methods Med."},{"issue":"6","key":"10.1016\/j.prp.2025.156301_bib62","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.euo.2021.10.003","article-title":"Diagnostic accuracy of novel urinary biomarker tests in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis","volume":"4","author":"Laukhtina","year":"2021","journal-title":"Eur. Urol. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2025.156301_bib63","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamaoncol.2024.6160","article-title":"Urinary DNA methylation test for bladder cancer diagnosis","volume":"11","author":"Jeong","year":"2025","journal-title":"JAMA Oncol."},{"issue":"191","key":"10.1016\/j.prp.2025.156301_bib64","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.24976\/Discov.Med.202436191.226","article-title":"Targeting LncRNA ADAMTS9-AS1 is a promising therapeutic strategy to inhibit the progression of bladder cancer","volume":"36","author":"Yu","year":"2024","journal-title":"Discov. Med."},{"issue":"186","key":"10.1016\/j.prp.2025.156301_bib65","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.24976\/Discov.Med.202436186.138","article-title":"Knockdown of YAP1 Reduces YTHDF3 to Stabilize SMAD7 and thus inhibit bladder cancer stem cell stemness","volume":"36","author":"Qiu","year":"2024","journal-title":"Discov. Med."},{"key":"10.1016\/j.prp.2025.156301_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116990","article-title":"Coumarin-Quinazolinone based photosensitizers: mitochondria and endoplasmic reticulum targeting for enhanced phototherapy via different cell death pathways","volume":"280","author":"Zhao","year":"2024","journal-title":"Eur. J. Med. Chem."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:35:41Z","timestamp":1767972941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825004947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":66,"alternative-id":["S0344033825004947"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156301","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the NR4A3-RNF139-ATF6 pathway as a therapeutic and diagnostic strategy in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156301"}}